Search

everythinglearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

The new assay can help develop products for hair re-growth.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Nitrate helps plants manage phosphate uptake and starvation responses through NIGT1 proteins.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

Ptprq has multiple forms that change during inner ear development.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Combining platelet-rich plasma injections and gel may effectively treat morphea, improving skin elasticity and reducing pain.

Super-activated platelet lysate significantly promotes hair regrowth in mice with androgenetic alopecia.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

sFRP4 partially inhibits hair regeneration, but the study needs clearer data analysis and better explanation of the process.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

A new compound shows promise as a topical treatment for hair loss.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

Progesterone and its metabolites affect myelin protein expression differently in male and female rat Schwann cells.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.